Hulbert M F, Vernon S A
Academic Unit of Ophthalmology, University Hospital, Nottingham, UK.
Eye (Lond). 1992;6 ( Pt 5):456-60. doi: 10.1038/eye.1992.96.
Twenty-one diabetics who had had bilateral retinal panphotocoagulation preserving a visual acuity sufficient to pass the Driver and Vehicle Licensing Centre (DVLC) requirements were assessed with regard to their ability to satisfy the DVLC visual field requirements. Of the 19 patients treated with the laser alone, 17 met the requirements for a licence to drive a private vehicle. The use of the Xenon photocoagulator and large total burn area following laser was found to be associated with an increased risk of DVLC field test failure. Adequate PRP with 200 micron burns appeared to induce neovascular regression and be compatible with passing the DVLC field regulations in many patients. Panphotocoagulation of patients with early proliferative retinopathy using 200 micron burns does not appear to jeopardise a driving licence. Guidelines for laser treatment in diabetic retinopathy aimed at preserving the driving field are presented.
对21名接受过双眼视网膜全光凝治疗且视力足以满足英国交通管理局(DVLC)要求的糖尿病患者,就其能否满足DVLC视野要求进行了评估。在仅接受激光治疗的19名患者中,有17名符合驾驶私家车的执照要求。发现使用氙光凝器以及激光治疗后总灼伤面积较大与DVLC视野测试失败风险增加有关。在许多患者中,采用200微米光斑的充分视网膜光凝似乎可促使新生血管消退并符合DVLC视野规定。对早期增殖性视网膜病变患者采用200微米光斑进行全光凝似乎不会影响驾驶执照的获取。本文提出了旨在保留驾驶视野的糖尿病视网膜病变激光治疗指南。